Abiopharma

Security Federal Announces Corrected Dividend of $0.16 per share in Connection with its Previously Announced Quarterly Dividend

Johnson & Johnson - Johnson & Johnson highlights promising first-in-human Erda-iDRS (formerly TAR-210) results in intermediate-risk non-muscle-invasive bladder cancer

Johnson & Johnson highlights promising first-in-human Erda-iDRS (formerly TAR-210) results in intermediate-risk non-muscle-invasive bladder cancer

Johnson & Johnson highlights promising first-in-human Erda-iDRS (formerly TAR-210) results in intermediate-risk non-muscle-invasive bladder cancer

Tevogen.AI Reports Advancements in PredicTcell™ Beta, Demonstrates Improved Precision Metrics and Expands Proprietary AI Infrastructure

Campbell’s Appoints Joshua Levine Chief Investor Relations Officer

Holding(s) in Company

BBWI Deadline: Rosen Law Firm Urges Bath & Body Works, Inc. (NYSE: BBWI) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights

Praetorian Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing March 16, 2026

Netflix to Announce First Quarter 2026 Financial Results

Net Asset Value(s)

Net Asset Value(s)

GSK’s RSV Vaccine, AREXVY, Approved in US for Expanded Age Indication in Adults Aged 18–49 Years at Increased Risk

Toll Brothers Announces Final Opportunity to Purchase Model Homes at The Evergreens at The Meadows in Lake Forest, California

📋 Bozic Carmen (Officer) plans to sell 2K shares of VERTEX PHARMACEUTICALS INC / MA (at $481.79 each, total $1.1M) Filed: Mar 13, 2026 | ID: 002279